ArticleOpen forum infectious diseases2018

A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program.

Mark Redell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.